Abstract
A dose-finding study was undertaken to determine the maximum-tolerated dose, and the recommended dose of docetaxel in combination with 12-h timed (22:00-10:00) flat infusion of 5-fluorouracil (5-FU) in metastatic breast cancer patients. This schedule seems to reduce the occurrence of stomatitis of the docetaxel and infusional 5-FU regimen.
Original language | English |
---|---|
Pages (from-to) | 618-620 |
Number of pages | 3 |
Journal | British Journal of Cancer |
Volume | 91 |
Issue number | 4 |
Publication status | Published - Aug 16 2004 |
Keywords
- 5-fluorouracil
- Breast cancer
- Docetaxel
ASJC Scopus subject areas
- Cancer Research
- Oncology